Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

CCCCCCCC
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in C4 THERAPEUTICS INC

BANK OF AMERICA CORP /DE/ holds 2.7M shares of CCCC (C4 THERAPEUTICS INC), worth $12.4M as of 2026-Q2. The position was increased (+12.6% shares). CCCC represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$12.4M

Current Shares

2.7M

Total Value Change

+$6.4M

Total Shares Change

+978,717

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.7M
+12.6%
$12.4M0.0%$4.67
31
2026-Q1
Decreased
2.4M
-1.2%
$6.2M0.0%$2.95
0
2025-Q4
Increased
2.4M
+16.3%
$4.6M0.0%$1.96
31
2025-Q3
Increased
2.1M
+2.3%
$4.6M0.0%$2.23
27
2025-Q2
Increased
2M
+0.9%
$2.9M0.0%$1.40
26
2025-Q1
Increased
2M
+18.7%
$3.2M0.0%$1.75
31
2024-Q4
New
1.7M
-
$6M0.0%$3.64
38

Other major holders of CCCC: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used